Diagnostic value of neuropsychological tests in mild cognitive impairment comorbid with Parkinson’s disease
Journal Title: Psychiatria Polska - Year 2014, Vol 48, Issue 2
Abstract
Mild cognitive impairment (MCI) is present in on average one-fourth of Parkinson’s disease (PD) patients with no dementia diagnosis. Only recently has PD-MCI been treated as a new diagnostic entity. In 2012, unified criteria were adopted which allow both diagnosing MCI in Parkinson’s disease (PD-MCI) and further classification taking into account the profile of cognitive dysfunctions and the probability of evolution towards dementia. The diagnostic criteria were presented in the form of stipulations and guidelines assuming that diagnostic process is based on the neuropsychological assessment of the patient. The notion of MCI had been borrowed and for a couple of years had been relying on definitions developed in relation to Alzheimer’s disease. For the first time, in the proposed criteria memory dysfunction is not the basis of classification. Only two categories of dysfunctions have been retained, single domain and multiple-domain. Whether the adopted criteria will contribute to an accurate diagnosis of cognitive dysfunctions and PD-specific dementing processes remains an open question. In spite of some limitations, the presented criteria can certainly improve the efficacy of monitoring the patient’s state at the same time allowing the hope for an appropriate therapy and a higher quality of life. Moreover, the unification of diagnostic criteria will be crucial in assessing usefulness of neuropsychological test instruments as a basic method of investigating neurodegenerative processes not only in PD.
Authors and Affiliations
Ilona Laskowska, Andrzej Koczorowski, Dariusz Koziorowski, Ludwika Gawryś
Keywords
Related Articles
- EP ID EP126925
- DOI -
- Views 119
- Downloads 0
Mikrobiota jelitowa – klucz do zrozumienia patofizjologii jadłowstrętu psychicznego?
Jadłowstręt psychiczny jest zaburzeniem psychicznym wiążącym się z bardzo poważnymi konsekwencjami dla zdrowia fizycznego i psychicznego pacjentów. Ze względu na złożony obraz kliniczny, na który składają się liczne obja...
Interactions between synthetic drugs used in treatment of selected central nervous system disorders and dietary supplements and herbal drugs
The risk of interaction between dietary supplements, herbal drugs and synthetic drugs increases when patients are treated chronically, e.g. due to impairment of central nervous system (CNS) – depression, psychotic disord...
Prężność jako predyktor zdrowia psychicznego kobiet odbywających karę pozbawienia wolności
Cel pracy Celem niniejszych badań była analiza, w jaki sposób prężność psychiczna różnicuje stan psychiczny kobiet odbywających karę pozbawienia wolności oraz co stanowi predyktor samopoczucia psychicznego w tej grupie....
Trening metapoznawczy dla chorych na schizofrenię. Opis metody i doświadczeń klinicznych
Celem artykułu jest prezentacja nowej, ustruktualizowanej metody grupowej terapii poznawczej – opracowanego w 2005 roku przez S. Moritza i T.S. Woodwarda treningu meta-poznawczego dla pacjentów chorych na schizofrenię. M...
Differences in severity and comorbidity of panic and depressive symptoms in difficult and aspirin-induced asthma
Summary Aim. The author examined psychiatrically a group of 106 patients with difficult asthma and 100 patients with aspirin-induced asthma. Method. 106 consecutive adults with confirmed, physician-diagnosed difficult...